“kite-pharma” Archives

in
Entry Author Date Location
Unanimous Advice To FDA: Approve Landmark CAR-T Cancer Therapy 07/12/17 National
ASCO Roundup: Checkpoint Combos, Tumor Profiling, Financial Toxicity 06/06/17 National
Bio Roundup: Big Apple Mo’, Checkpoint Yes and No, CAR-T Death & More 05/12/17 National
Kite CAR-T Death: An Unwelcome Mystery as FDA Mulls Approval 05/08/17 National
Bio Roundup: Spinraza Woes, Science March, Baseline Launch & More 04/21/17 National
Ex-Dendreon CEO, Gold, Returns to Wall Street as Alpine, Nivalis Merge 04/18/17 Seattle
AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down 04/06/17 National
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Possible Cures. Mystery Deaths. Daunting Costs. Can CAR-T Be Tamed? 03/13/17 National
Bio Roundup: Healthcare Is Hard, “Slow” FDA, Drugging RNA & More 03/03/17 National
After Trial Deaths, Juno Pivots and Scraps Lead CAR-T Therapy 03/01/17 Seattle
With Eye On FDA, Kite Says CAR-T For Lymphoma Holds Up After 6 Months 02/28/17 National
Armed with $16M, Cue Biopharma Aims for Selective Immunotherapy 01/24/17 Boston
Bio Roundup: Crazy ’16, Trials of ’17, Senate on Drugs & More 12/23/16 National
14 for ’17: Key Clinical Data To Watch For Next Year (Part 2) 12/22/16 National
TCR2 Therapeutics Unveils New Cancer Therapy Approach and $44.5M Round 12/08/16 Boston
At Late-Night ASH Talk, Juno Execs Look Beyond Stalled “Rocket” Trial 12/06/16 Seattle
In Year of CAR-T Trouble, Can Bluebird, Penn Make Headway in Myeloma? 11/30/16 Boston
Two More Deaths In Trial Halt Juno’s Top CAR-T Treatment Again 11/23/16 Seattle
All In One Place: A New Immuno-Oncology Trial Resource 10/19/16 National
Checkpoints In Lung Cancer, and Other Oncology News From Europe 10/11/16 National
Bio Roundup: CAR-T & Migraine Races, Intra-Cellular, Rockefeller & More 09/30/16 National
Aligned With Roche, SQZ Bio Gets $16M to Push Cell Therapies to Clinic 09/30/16 Boston
Will Programmable Immune “Cellbots” Be the Next Weapon Against Cancer? 09/29/16 San Francisco
Kite Unveils Anticipated CAR-T Cancer Data: Positive But Not Complete 09/26/16 National
Novartis Disbands T Cell Group But Promises To Press Ahead In CAR-T Race 08/31/16 National
Bio Roundup: Precision Med and Google, Heron, Lilly, Sarepta & More 08/12/16 National
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Alpine Immune Sciences, Former Dendreon CEO’s Latest Startup, Gets $48M 06/13/16 Seattle
Bankrupt Biotech KineMed Owes More Than $1M To Gates, Others 05/13/16 San Francisco
Page 1 of 3 next page »